https://pioneerinstitute.org/wp-content/uploads/MBTA-Subway-Returns-Feature.jpg 450 600 Eamon McCarthy Earls https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Eamon McCarthy Earls2019-04-01 16:48:532019-07-11 11:23:44MBTAAnalysis: A look inside the MBTA
The MBTA shuttles over a million passengers a day around Greater…
https://pioneerinstitute.org/wp-content/uploads/CloseupClock-1.jpg 739 1244 Mary Connaughton https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Mary Connaughton2017-02-20 12:34:192017-02-21 09:47:58The Clock is Ticking…….
The clock is ticking towards December 30, 2017. As part of…
https://pioneerinstitute.org/wp-content/uploads/WordPress-Blog-Post-Featured-Image-4.png 512 1024 William Smith https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png William Smith2021-02-03 10:45:182021-02-05 10:53:55ICER Proves Its Lack of Business Acumen, Again
A recent Institute for Clinical and Economic Review (ICER) “Report on Unsupported Price Increases,” concluded that: “Among the top drugs with price increases in 2019…ICER determined that seven of 10 lacked adequate new evidence to demonstrate a substantial clinical benefit that was not yet previously known.” The impression left by the report is that drug companies arbitrarily raise prices without good reason. As with so many ICER products, the study is misleading and demonstrates a profound lack of business acumen.